glp 1 agonists and anesthesia New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review GLP-1 drugs and aspiration risk

Separate gut-brain circuits for fat and sugar reinforcement combine to promote overeating

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

Gender-specific risk factors for incident sarcopenia: 8-year follow-up of the English longitudinal study of ageing

Probiotics are typically safe but are not appropriate for some immunocompromised people

This remains a hypothesis to be tested rather than an established conclusion

GLP-1 reduces glucagon secretion from the pancreas